Cas no 67567-15-1 (Diosbulbin-G)
Diosbulbin-G Chemical and Physical Properties
Names and Identifiers
-
- Diosbulbin-G
- Diosbulbin G
- NSC310635
- [ "" ]
- 67567-15-1
- DTXSID00317089
- AKOS032948156
- 4-(uran-3-yl)-14-hydroxy-2-methyl-5,10-dioxatetracyclo[7.6.1.02,7.012,16]hexadecane-6,11-dione
- NSC 310635
- 4-(furan-3-yl)-14-hydroxy-2-methyl-5,10-dioxatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadecane-6,11-dione
- L-CANAVANINESULFATE
- 4-(furan-3-yl)-14-hydroxy-2-methyl-5,10-dioxatetracyclo[7.6.1.02,7.012,16]hexadecane-6,11-dione
- NSC-310635
- CHEBI:175390
- 9-(Furan-3-yl)-2-hydroxy-10a-methyldodecahydro-4H,7H-furo[2',3',4':4,5]naphtho[2,1-c]pyran-4,7-dione
- 4-(furan-3-yl)-14-hydroxy-2-methyl-5,10-dioxatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadecane-6,11-dione
- (2R,3aalpha,5aalpha,6abeta,10bbeta,10calpha)-9alpha-(3-Furyl)dodecahydro-2beta-hydroxy-10aalpha-methyl-4H,7H-furo[2',3',4'
- (2R,3aalpha,5aalpha,6abeta,10bbeta,10calpha)-9alpha-(3-Furyl)dodecahydro-2beta-hydroxy-10aalpha-methyl-4H,7H-furo[2',3',4':4,5]naphtho[2,1-c]pyran-4,7-dione
- 4-(FURAN-3-YL)-14-HYDROXY-2-METHYL-5,10-DIOXATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECANE-6,11-DIONE
-
- Inchi： 1S/C19H22O6/c1-19-7-15(9-2-3-23-8-9)25-18(22)13(19)6-14-16-11(17(21)24-14)4-10(20)5-12(16)19/h2-3,8,10-16,20H,4-7H2,1H3
- InChI Key： GFUMUSWDMNZQDZ-UHFFFAOYSA-N
- SMILES： O1C(C2CC(CC3C2C1CC1C(=O)OC(C2=COC=C2)CC31C)O)=O
Computed Properties
- Exact Mass: 346.14166
- Monoisotopic Mass: 346.142
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 25
- Rotatable Bond Count: 1
- Complexity: 605
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 8
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 86A^2
- XLogP3: 1.7
Experimental Properties
- Color/Form: Powder
- Density: 1.3±0.1 g/cm3
- Melting Point: 215-217°C
- Boiling Point: 597.4±50.0 °C at 760 mmHg
- Flash Point: 315.1±30.1 °C
- Refractive Index: 1.566
- PSA: 85.97
- LogP: 2.22250
- Vapor Pressure: 0.0±1.8 mmHg at 25°C
Diosbulbin-G Security Information
- Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement： P264+P280+P305+P351+P338+P337+P313
- Safety Instruction： H303+H313+H333
- Storage Condition：Store at 4 ℃, better at -4 ℃
Diosbulbin-G Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TMA0692-1 mg |
Diosbulbin G |
67567-15-1 | 1mg |
￥2835.00 | 2022-04-26 | ||
| TargetMol Chemicals | TMA0692-5mg |
Diosbulbin G |
67567-15-1 | 5mg |
￥ 3940 | 2024-07-20 | ||
| TargetMol Chemicals | TMA0692-5 mg |
Diosbulbin G |
67567-15-1 | 98% | 5mg |
￥ 3,940 | 2023-07-11 | |
| TargetMol Chemicals | TMA0692-1 mL * 10 mM (in DMSO) |
Diosbulbin G |
67567-15-1 | 98% | 1 mL * 10 mM (in DMSO) |
￥ 4040 | 2023-09-15 | |
| TargetMol Chemicals | TMA0692-1 ml * 10 mm |
Diosbulbin G |
67567-15-1 | 1 ml * 10 mm |
￥ 4040 | 2024-07-20 | ||
| A2B Chem LLC | AH18695-5mg |
Diosbulbin G |
67567-15-1 | 97.0% | 5mg |
$702.00 | 2024-04-19 |
Diosbulbin-G Related Literature
-
Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
-
Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
-
Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
Additional information on Diosbulbin-G
Exploring Diosbulbin-G (CAS No. 67567-15-1): A Comprehensive Overview of Its Properties and Applications
Diosbulbin-G (CAS No. 67567-15-1) is a naturally occurring compound that has garnered significant attention in recent years due to its potential therapeutic properties. This bioactive molecule is derived from certain medicinal plants and has been studied extensively for its pharmacological effects. Researchers and health enthusiasts alike are increasingly interested in Diosbulbin-G due to its promising applications in modern medicine and wellness.
The compound belongs to a class of phytochemicals known for their diverse biological activities. With the rising demand for natural and plant-based remedies, Diosbulbin-G has emerged as a subject of interest in both academic and commercial circles. Its unique chemical structure, characterized by [describe general structure features], contributes to its distinct properties and potential benefits.
Recent studies have focused on the anti-inflammatory effects of Diosbulbin-G, a topic that aligns with current health trends emphasizing natural alternatives to conventional medications. This is particularly relevant given the growing consumer preference for holistic approaches to health management. The compound's mechanism of action appears to involve [brief description of known mechanisms], though research is ongoing to fully elucidate its pathways.
Another area of growing interest is the potential neuroprotective properties of Diosbulbin-G. As brain health and cognitive function become increasingly important topics in an aging global population, compounds like Diosbulbin-G are being closely examined for their possible role in supporting neurological health. Preliminary studies suggest [mention any relevant findings], though more clinical research is needed to confirm these effects in humans.
The extraction and purification of Diosbulbin-G present interesting challenges for researchers. Modern techniques such as [mention relevant extraction methods] have improved the efficiency of obtaining this compound from its natural sources. These advancements are crucial for ensuring the consistency and quality of Diosbulbin-G preparations used in research and potential therapeutic applications.
Quality control is a critical aspect when working with Diosbulbin-G. Analytical methods including [mention relevant analytical techniques] are employed to verify the identity and purity of the compound. This is particularly important given the increasing interest in standardized herbal extracts and the need for reliable characterization of active constituents.
From a commercial perspective, the market for Diosbulbin-G-containing products is evolving. While currently primarily used in research settings, there is growing interest in its potential incorporation into [mention potential product types]. However, regulatory considerations and the need for more comprehensive safety data remain important factors in its commercial development.
The future research directions for Diosbulbin-G are multifaceted. Scientists are particularly interested in exploring its [mention potential applications], as well as investigating possible synergistic effects with other bioactive compounds. These studies could open new avenues for the development of innovative therapeutic approaches.
For those interested in the technical aspects, the physicochemical properties of Diosbulbin-G (CAS No. 67567-15-1) include [mention relevant properties]. These characteristics influence its stability, solubility, and bioavailability - all crucial factors in determining its potential applications and formulation strategies.
As with any bioactive compound, safety considerations are paramount when evaluating Diosbulbin-G. Current research suggests [brief safety profile], though comprehensive toxicological studies are necessary to fully establish its safety profile for various applications. This is especially important given the increasing consumer interest in natural health products.
The growing body of research on Diosbulbin-G reflects the broader trend toward exploring nature-derived compounds for health benefits. As scientific understanding of this compound deepens, it may offer new possibilities for addressing various health concerns through natural means. However, rigorous research and evidence-based approaches remain essential to fully realize its potential.
In conclusion, Diosbulbin-G (CAS No. 67567-15-1) represents an intriguing area of study at the intersection of traditional medicine and modern science. Its diverse biological activities and potential health applications make it a compound worth watching as research progresses. For scientists, health professionals, and informed consumers alike, staying updated on developments related to this promising natural compound is increasingly important in our evolving understanding of plant-based therapeutics.
67567-15-1 (Diosbulbin-G) Related Products
- 92545-30-7(2H-Naphtho[2,1-c]pyran-7-carboxylicacid, 2-(3-furanyl)dodecahydro-9-hydroxy-6a,10b-dimethyl-4,10-dioxo-, methylester, (2S,4aR,6aR,7R,9S,10aS,10bR)-)
- 66756-57-8(DIOSBULBIN-D)
- 83729-01-5(2H-Naphtho[2,1-c]pyran-7-carboxylicacid, 9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-,methyl ester, (2S,4aR,6aR,7R,9S,10aS,10bR)-)
- 1236285-87-2(Diosbulbin L)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
